Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials

被引:17
|
作者
Tamburini, Emiliano [1 ]
Tassinari, Davide [2 ]
Ramundo, Matteo [1 ]
De Stefano, Alfonso [3 ]
Viola, Massimo Giuseppe [4 ]
Romano, Carmela [3 ]
Elia, Maria Teresa [1 ]
Zanaletti, Nicoletta [3 ]
Rudnas, Britt [5 ]
Casadei-Gardini, Andrea [6 ,7 ]
Delrio, Paolo [8 ]
Toma, Ilaria [1 ]
Granata, Vincenza [9 ]
Petrucelli, Luciana [1 ]
Avallone, Antonio [3 ]
机构
[1] Cardinale G Panico Tricase City Hosp, Dept Oncol & Palliat Care, Tricase, Italy
[2] City Hosp, Dept Oncol, Rimini, Italy
[3] IRCCS Fdn G Pascale, Ist Nazl Tumori, Expt Clin Abdominal Oncol Unit, Naples, Italy
[4] Cardinale G Panico Tricase City Hosp, Dept Surg, Tricase, Italy
[5] IRCCS Ist Romagnolo Studio Tumori IRST, Unit Biostat & Clin Trials, Meldola, Italy
[6] Univ Vita Salute San Raffaele, Sch Med, Milan, Italy
[7] IRCCS San Raffaele Sci Inst, Unit Oncol 3, Milan, Italy
[8] IRCCS Fdn G Pascale, Ist Nazl Tumori, Colorectal Oncol Surg, Naples, Italy
[9] IRCCS Fdn G Pascale, Ist Nazl Tumori, Radiol Unit, Naples, Italy
关键词
Rectal cancer; Adjuvant chemotherapy; Fluoropyrimidine; Oxaliplatin; FOLFOX XELOX; TOTAL MESORECTAL EXCISION; III COLON-CANCER; PREOPERATIVE CHEMORADIOTHERAPY; OPEN-LABEL; POSTOPERATIVE CHEMORADIOTHERAPY; FOLLOW-UP; FLUOROURACIL; RADIOTHERAPY; OXALIPLATIN; MULTICENTER;
D O I
10.1016/j.critrevonc.2022.103627
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Highlights: Although no definitive data exist in literature, adjuvant chemotherapy is usually recommended in patients with radically resected stage III rectal cancer treated with neo-adjuvant chemo-radiotherapy. We performed a systematic review of literature with direct and indirect comparisons to assess the role of adjuvant mono or poli-chemotherapy in radically resected rectal cancer treated with neoadjuvant chemo-radiotherapy. Neither chemotherapy (mono-or poli-chemotherapy) nor polichemotherapy with oxaliplatin-containing regimens seems to improve Overall Survival and Disease-Free Survival in patients with radically resected rectal cancer treated with neoadjuvant chemo-adiotherapy. Neither the entire population of patients radically resected after neoadjuvant chemotherapy, nor high risk patients seem to benefit from adjuvant chemotherapy. Our data seem to suggest the need of review the actual international guidelines that suggest the need of adjuvant chemotherapy at least in high risk rectal cancer treated with surgery and neoadjuvant chemo-radiotherapy.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Neoadjuvant Radiotherapy for Rectal Cancer: Meta-analysis of Randomized Controlled Trials
    Nuh N. Rahbari
    Heike Elbers
    Vasileios Askoxylakis
    Edith Motschall
    Ulrich Bork
    Markus W. Büchler
    Jürgen Weitz
    Moritz Koch
    Annals of Surgical Oncology, 2013, 20 : 4169 - 4182
  • [42] A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy, and surgery) vs. standard long-term chemoradiation therapy (neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy) in locally advanced rectal cancer
    Foroughi, Freshte
    Javadinia, Seyed Alireza
    Salek, Roham
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [43] Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
    Alvarado-Miranda, Alberto
    Arrieta, Oscar
    Gamboa-Vignolle, Carlos
    Saavedra-Perez, David
    Morales-Barrera, Rafael
    Bargallo-Rocha, Enrique
    Zinser-Sierra, Juan
    Perez-Sanchez, Victor
    Ramirez-Ugalde, Teresa
    Lara-Medina, Fernando
    RADIATION ONCOLOGY, 2009, 4
  • [44] Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Colorectal Cancer Meta-analysis of Randomized Controlled Trials
    Huang, Lei
    Li, Tuan-Jie
    Zhang, Jian-Wen
    Liu, Sha
    Fu, Bin-Sheng
    Liu, Wei
    MEDICINE, 2014, 93 (28) : e231
  • [45] Efficacy and safety of adjuvant chemotherapy for locally advanced cervical cancer: A systematic review and meta-analysis
    Ma, Xiao
    Fang, Jin
    Zhang, Lu
    Huang, Yao
    Shen, Hui
    Ma, Xiaohua
    Zhang, Shuixing
    Zhang, Bin
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 184
  • [46] Comparison of long course and short course preoperative radiotherapy in the treatment of locally advanced rectal cancer: a systematic review and meta-analysis
    Yu, Yongjun
    Li, Yuwei
    Xu, Chen
    Zhang, Zhao
    Zhang, Xipeng
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (01) : 17 - 27
  • [47] Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART)
    Ricardi, Umberto
    Racca, Patrizia
    Franco, Pierfrancesco
    Munoz, Fernando
    Fanchini, Laura
    Rondi, Nadia
    Dongiovanni, Vincenzo
    Gabriele, Pietro
    Cassoni, Paola
    Ciuffreda, Libero
    Morino, Mario
    Filippi, Andrea Riccardo
    Aglietta, Massimo
    Bertetto, Oscar
    MEDICAL ONCOLOGY, 2013, 30 (02)
  • [48] Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis
    Yang, Yong-Jing
    Cao, Ling
    Li, Zhi-Wen
    Zhao, Ling
    Wu, Hong-Fen
    Yue, Dan
    Yang, Jin-Lei
    Zhou, Zhi-Rui
    Liu, Shi-Xin
    ONCOTARGET, 2016, 7 (29) : 45513 - 45524
  • [49] Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART)
    Umberto Ricardi
    Patrizia Racca
    Pierfrancesco Franco
    Fernando Munoz
    Laura Fanchini
    Nadia Rondi
    Vincenzo Dongiovanni
    Pietro Gabriele
    Paola Cassoni
    Libero Ciuffreda
    Mario Morino
    Andrea Riccardo Filippi
    Massimo Aglietta
    Oscar Bertetto
    Medical Oncology, 2013, 30
  • [50] Neo-adjuvant chemotherapy alone for the locally advanced rectal cancer: a systematic review
    Manatakis, Dimitrios K. .
    Gouvas, Nikolaos
    Souglakos, John
    Xynos, Evangelos
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (09) : 1570 - 1580